6:30 pm – 8:30 pm

Welcome Reception

7:00 am – 8:00 am

Breakfast

8:00 am – 10:00 am

Oral Abstract Session 1: Regulation of Allergic Inflammation

Chair: R. Stokes Peebles, United States

8:00 am – 8:20 am

Identification of a Human Th2 Multipotent Progenitor

Patrick J. Brennan, United States

8:20 am – 8:40 am

Epithelial-Intrinsic Defects In TGFβR Signaling Drive the Development of Eosinophilic Esophagitis

Pamela Guerrerio, United States

8:40 am – 9:00 am

Preventive but not Therapeutic Administration of a Bacterial Lysate Suppresses Experimental Allergic Asthma

Vadim Pivniouk, United States

9:00 am – 9:20 am

Enhanced ST2 Expression is Associated with Pathogenicity in Treg Lacking PGI2 Signaling

Allison E. Norlander, United States

9:20 am – 9:40 am

IL-4R⍺ Signaling Drives Mast Cell-Derived Oncostatin M and an Innate Inflammatory Response in AERD

Tanya M. Laidlaw, United States

9:40 am – 10:00 am

Asthma-protective Agents in Dust from Traditional Farm Environments

Donata Vercelli, United States

10:00 – 10:30 am

Break

10:30 am – 11:20 am

Keynote Lecture: IgE, FcεRI, and Numbers

Chair: Bruce S. Bochner, United States

Donald W. MacGlashan, Jr., United States

11:30 am – 12:30 am

Oral Abstract Session 2: B Cells and Allergic Diseases

Chair:  Mübeccel Akdis, Switzerland

11:30 am – 11:50 am

A Distinct Phenotype of Polarized Memory B Cell Holds IgE Memory

Allyssa Phelps, Canada

11:50 am – 12:10 pm

Pathogenic IgE-Fated B Cell Memory Retains Functional Plasticity

Atai Ariaz, Canada

12:10 pm – 12:30 pm

Antibody Affinity Birth Through Somatic Hypermutation

Duane Wesemann, United States

12:30 pm – 2:00 pm

Lunch

12:30 pm – 2:00 pm

Satellite Symposium: A Focus on Type 2 Inflammation in Disease

Speaker: Leonard Bacharier, United States

Lunch provided

Sponsored by:

2:00 pm – 3:40 pm

Oral Abstract Session 3: Type 2 Inflammation Pathobiology

Chair: Sven-Erik Dahlén, Sweden

2:00 pm – 2:20 pm

Platelet-Derived Cysteinyl Leukotrienes Drive Sexually Dimorphic Features of Type 2 Inflammation

Joshua A. Boyce, United States

2:20 pm – 2:40 pm

House Dust Mite Allergen Induces PAR-1 Dependent Release of Calcitonin-Gene Related Peptide from Cultured Human Pulmonary Neuroendocrine Cells

Paul Forsythe, Canada

2:40 pm – 3:00 pm

Oxidatively Driven Programmed Cell Death and Mitophagic Survival Converge to Alter Epithelial Cell Phenotypes and Function of Relevance to Asthma

Sally E. Wenzel, United States

3:00 pm – 3:20 pm

Contribution of Oleoylethanolamide and CB2 receptor in Eosinophilic Airway Inflammation of Bronchial Asthma

Ga Young Ban, Korea

3:20 pm – 3:40 pm

Mechanism of Innate Memory Formation in ILC2s and its Relevance for Asthma 

Rafeul Alam, United States

3:40 pm – 4:00 pm

Break

4:00 pm – 4:50 pm

Relaxing Lecture: Misinformation: The Battle Continues!

Chair: Judah Denburg, Canada

Timothy Caulfield, Canada

5:00 pm – 5:30 pm

Poster Lightning Round 1

Chair: Jean Marshall, Canada

5:00 pm – 5:03 pm

Dysregulated Immune Landscape of Persistent COVID19 Olfactory Dysfunction

Lora Bankova, United States

5:03 pm – 5:06 pm

Why African American Children with Food Allergy have Higher Risk of Asthma: Studying the Interrelated Links of Health Disparities, Environment and Microbiome

Mahboobeh Mahdavinia, United States

5:06 pm – 5:09 pm

Characterization of a T follicular Helper Cell Subset in a Monogenic form of Food Allergy

Stephanie C. Eisenbarth, United States

5:09 pm – 5:12 pm

Receptor-Ligand Interaction Between GPR15+ T Cells and GPR15L May Facilitate the Extravasation of T Cells Into the Esophageal Mucosa in Eosinophilic Esophagitis (EoE)

Moumita Bhowmik, United States

5:12 pm – 5:15 pm

Drug-induced Anaphylaxis Uncommon Among 252 Patients with Mastocytosis

Theo Gulen, Sweden

5:15 pm – 5:18 pm

Risk of Childhood Wheeze and Asthma Associated with Grandparental Asthma in a Three Generations Cohort

Syed H. Arshad, United Kingdom

5:18 pm – 5:21 pm

Taurine and Sphingolipid Metabolites Identify Unique Response Signatures to Omalizumab and Mepolizumab in Asthma

Ayobami Akenroye, United States

5:21 pm – 5:24 pm

Elucidation of the Underlying Mechanism of Itching in Atopic Dermatitis

Kenji Izuhara, Japan

5:24 pm – 5:27 pm

Cytokine Stimulation of Airway Mucins

Kristina Johansson, Sweden

5:27 pm – 5:30 pm

Maternal Atopic History is Associated with Decreased TLR2 and GM-CSFR Expression on Infant Hematopoietic Progenitor Cells

David M. Putman, Canada

5:30 pm – 7:30 pm

Poster Session 1

COVID-19 and Allergic Disease

SARS-CoV-2 Infection in Pregnancy Alters Maternal and Cord Blood Immune Cell Composition and Function at Delivery

David M. Putman, Canada

Characterizing the Release of the Proinflammatory Cytokine TSLP from Lung Epithelial Cells in Response to SARS-CoV-2 Infection

Luke Gerla, Canada

Dysregulated Immune Landscape of Persistent COVID19 Olfactory Dysfunction

Lora Bankova, United States

Effects of Age and Wildfire Smoke Exposure on Anti-SARS-CoV-2 Vaccine Immunity: Role of Natural Killer Cells

Gursharan Kaur Sanghar, United States

Food and Drug Allergies and Gastrointestinal Disorders

Why African American Children with Food Allergy have Higher Risk of Asthma: Studying the Interrelated Links of Health Disparities, Environment and Microbiome

Mahboobeh Mahdavinia, United States

Characterization of a T follicular Helper Cell Subset in a Monogenic form of Food Allergy

Stephanie C. Eisenbarth, United States

Dietary Intervention in LTP Allergic Patients: Safety and Clinical Response

Maria J. Torres, Spain

Receptor-Ligand Interaction Between GPR15+ T Cells and GPR15L May Facilitate the Extravasation of T Cells into the Esophageal Mucosa in Eosinophilic Esophagitis (EoE)

Moumita Bhowmik, United States

Genomics, Environmental Factors and Precision Medicine

Risk of Childhood Wheeze and Asthma Associated with Grandparental Asthma in a three generations cohort

Syed H. Arshad, United Kingdom

Taurine and Sphingolipid Metabolites Identify Unique Response Signatures to Omalizumab and Mepolizumab in Asthma

Ayobami Akenroye, United States

Transcriptional Gene Networks in the Lungs of Mice Exposed to Asthma-Protective Microbial Agents: A Comparative Analysis

Sydney VanLinden, United States

Epidemiological Transition of Wheezing-associated Viruses. The Role of New Viruses

Alejandra Osorio Martínez, Mexico

Pathophysiology of Allergic Disorders and Inflammation

Which is Important for the Pathogenesis of Allergic Bronchopulmonary Aspergillosis/Mycosis, IgE or Eosinophils?

Koichiro Asano, Japan

Trained Immunity and Macrophage Reprogramming in Allergic Asthma

Jiu-Yao Wang, Taiwan

Exploring the Therapeutic Potential of Probiotic-Derived Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) Protein as an Anti-Allergy Agent

Pei-Chi Chen, Taiwan

Impact of Circulating Angiomotin and Angiostatin on Clinical Variables in Patients with Asthma

An Soo Jang, Korea

Elucidation of the Underlying Mechanism of Itching in Atopic Dermatitis

Kenji Izuhara, Japan

Cytokine Stimulation of Airway Mucins

Kristina Johansson, Sweden

Maternal Atopic History is Associated with Decreased TLR2 and GM-CSFR Expression on Infant Hematopoietic Progenitor Cells

David M. Putman, Canada

Growth Patterns and Asthma in Early Childhood: The CHILD Cohort Study

Padmaja Subbarao,  Canada

Relevance of sIgE and sIgG4 to Cat and Dust Mite Allergens in relation to Asthma in the Project Viva Birth Cohort: The Modified Th2 Response Revisited

Thomas A.E. Platts-Mills,  United States

Circulating MicroRNA in Different Courses of Atopic Dermatitis

Nadine Herrmann,  Germany

Combined Metagenomic - and Culture-Based Approaches to Investigate Bacterial Strain-Level Associations with Medication-Controlled Mild-Moderate Atopic Dermatitis

Anne Marie Singh,  United States

Overexpression of miR-29b in Bronchial Biopsies from Individuals with Asthma Coincides with Reduced Levels of Soluble ST2 in Bronchial Lavage Fluid

Madeleine Rådinger,  Sweden

Demographic Encoded Phenotypes in Atopic Dermatitis and Related QoL- Cross Sectional Results from the ProRaD-study in 1011 patients

Laura Maintz,  Germany

Characterization of Extracellular Vesicles in the Peripheral Blood Of Atopic Dermatitis Patients

Pierre-Yves Mantel,  Switzerland

Oxidative-stress-induced Glucocorticoid Insensitivity in Human Airway Smooth Muscles In Vitro and Asthmatic Rhesus Macaques In Vivo

Angela Haczku,  United States

CFTR Regulates Airway Epithelial IL-33 Release and IL-33 Dependent Inflammation

R. Stokes Peebles Jr.,  United States

Urticaria, Angioedema, Anaphylaxis, Mastocytosis and Mast Cell Activation Disorders

Hereditary A-tryptasemia is Associated with Increased Risk for Anaphylaxis to Antibiotics and Biological Agents

Peter Korosec,  Slovenia

Minding the Gap Between Anaphylaxis Guidelines and Clinical Practice in Emergency Departments Across Age Groups

Tsung-Chieh Yao,  Taiwan

Drug-induced Anaphylaxis Uncommon Among 252 Patients with Mastocytosis

Theo Gulen, Sweden

Differential Urinary Mast Cell Mediators in Mastocytosis, Hereditary Alpha Tryptasemia and Atopic Patients

Mariana C. Castells,  United States

Treatment with the KIT Antibody Barzolvolimab Leads to a Profound Depletion of Skin Mast Cells and to Novel Insights into the Therapy of Mast Cell-driven Diseases

Diego Alvarado, United States

7:00 am – 8:00 am

Breakfast

8:00 am – 9:20 am

Oral Abstract Session 4: Mast Cells

Chair: Stephen Galli, United States

8:00 am – 8:20 am

Defining the Expression and Function of Siglec-9 and its Ligands on Mast Cells

Adrian Piliponsky,  United States

8:20 am – 8:40 am

Human Intraepithelial Mast Cell Differentiation and Effector Function are Directed by TGF-β Signaling

Daniel F. Dwyer, United States

8:40 am – 9:00 am

IgG:FcɣRIIb Signals Block Effector Programs of IgE:FcεRI-activated Mast Cells

Cynthia Kanagaratham, United States

9:00 am – 9:20 am

Activation of the Mas-Related G protein-Coupled Receptor MRGPRX2 with  Substance P Analogs Demonstrates the Importance of Key Residues

Marianna Kulka,  Canada

9:20 am – 10:00 am

Break

10:00 am – 10:50 am

Carl Prausnitz Lecture: Insights into Atopic Dermatitis

Chair: Donata Vercelli, United States

Raif Geha, United States

11:00 am – 12:15 pm

Pro/Con Debate: Biologics have Solved the Problem of Type 2 Asthma

Chair: Stephen T. Holgate, United Kingdom

Pro: Parameswaran Nair, Canada
Con: Sally Wenzel, United States

Lunch provided

12:30 pm – 4:30 pm

Optional Boat Ride

5:00 pm – 5:30 pm

Poster Lightning Round 2

Chair: Roma Sehmi, Canada

5:00 pm – 5:03 pm

Allergen-specific Type 2 Memory B Cells in Bee Venom Allergy are Modified Following Ultra-Rush Immunotherapy

Menno C. Van Zelm, Australia

5:03 pm – 5:06 pm

Novel Variants of Epitope 1 of Ara h 2 have Enhanced IgE Binding that Varies Among Subjects

Stephen C. Dreskin, United States

5:06 pm – 5:09 pm

Neuregulin-1 Partially Overcomes the Requirement for CD11c Expressing Cells to Survive a Respiratory Viral Infection

Mitchell H. Grayson, United States

5:09 pm – 5:12 pm

The Dermal Fibroblast Phenotype Determines Skin Mast Cell Reactivity

Anna Di Nardo, United States

5:12 pm – 5:15 pm

TSLP Trafficking in Allergen-Treated Airway Epithelial Cells: Colocalization with Rab11a Guanosine Triphosphatase

Marc Duchesne, Canada

5:15 pm – 5:18 pm

Comprehensive Profiling of Lipid Mediator Metabolites in Human Lung Mast Cells Reveals Selective Production Following IgE-dependent Activation

Anna-Karin Johnsson, Sweden

5:18 pm – 5:21 pm

Annexin A1 is a Cell-Intrinsic Regulator of Human Group 2 Innate Lymphoid Cells Via Zinc

Hiroki Kabata, Japan

5:21 pm – 5:24 pm

Metabolomics of Circulating Human Memory CD4+T effector and T regulatory Cells Reveals that Phenylalanine is a Metabolic Checkpoint of Pathogenic Th2 Cells Development

Milena Sokolowska, Switzerland

5:24 pm – 5:27 pm

Effective Delivery of miR-511-3p with Mannose-Decorated Exosomes with RNA Nanoparticles Confers Protection against Asthma

Peisong Gao, United States

5:27 pm – 5:30 pm

A Surfactant Protein-A Peptide Modulates Responses to Interleukin-13 in Asthma and Offers a Novel Therapeutic Alternative

Monica Kraft, United States

5:30 pm – 7:30 pm

Poster Session 2

Allergen Specific Immunotherapy

Allergen-specific Type 2 Memory B Cells in Bee Venom Allergy are Modified Following Ultra-Rush Immunotherapy

Menno C. Van Zelm, Australia

Modified Tree Nut Desensitization Protocol in Real-World Clinical Practice

Adnan M. Al Ali, Canada

Uniform Pulse of Th2 IL-6 Signaling and IL-10-Producing B Cells Marks the Initial Immune Switch in Insect Venom Allergen Immunotherapy

Markus Ollert, Luxembourg

Allergen-Neutralizing IgG Rapidly Rises In Dogs Vaccinated With Der f 2-Expressing Bioparticles

Guy Tropper, Canada

Allergens and Diagnosis of Allergy

In 12 Years Skin Prick Test Sensitization in Mexican Patients with Respiratory Allergy Increased and Differs Between Humid and Dry Zones

Désirée E. Larenas Linnemann, Mexico

Rapid Point-of-care Detection of EPX in Sputum

Parameswaran Nair, Canada

Novel Variants of Epitope 1 of Ara h 2 Have Enhanced IgE Binding That Varies Among Subjects

Stephen C. Dreskin, United States

Developing a Pipeline for the Characterization of Allergen Content and Adjuvant Activity of Allergen-Displaying Plant Bioparticles

Lorenz Aglas, Austria

Dendritic Cells, Mast Cells, Monocytes/Macrophages, Neutrophils, Eosinophils, Basophils and Epithelial Cells

Neuregulin-1 Partially Overcomes the Requirement for CD11c Expressing Cells to Survive a Respiratory Viral Infection

Mitchell H. Grayson, United States

Muscarinic M3 Receptor Involves in the Differentiation of M2 Macrophage in Allergic Airway Inflammation

Shin Ohta, Japan

Exosomal Let-7-mediated Regulation of Lipid Metabolism in Foamy Macrophage of Chronic Obstructive Pulmonary Disease (COPD)

Miao-Hsi Hsieh, Taiwan

Expression and Functions of Proteinase-Activated Receptor-2 in Human Intermediate Monocytes

Harissios Vliagoftis, Canada

TSLP Trafficking in Allergen-Treated Airway Epithelial Cells: Colocalization with Rab11a Guanosine Triphosphatase

Marc Duchesne, Canada

The Dermal Fibroblast Phenotype Determines Skin Mast Cell Reactivity

Anna Di Nardo, United States

Comprehensive Profiling of Lipid Mediator Metabolites in Human Lung Mast Cells Reveals Selective Production Following IgE-dependent Activation

Anna-Karin Johnsson, Sweden

A Novel Isoprenylation Inhibitor Suppresses Asthma-related Mast Cell Function

John J. Ryan, United States

How Flexible are Neutrophils to Opposing Signals?

Paola Andrea Martinez Murillo, Switzerland

Interleukin-5 Modifies The Expression Of Selected Interleukin-6 Family Members By Human Mast Cells And Enhances Mast Cell Interferon Responses

Jean Marshall, Canada

Lymphocytes and Mediators of Immunoregulation

Annexin A1 is a Cell-Intrinsic Regulator of Human Group 2 Innate Lymphoid Cells Via Zinc

Hiroki Kabata, Japan

Neuromedin-U/ NMU-R1 Axis Mediates Rapid Activation of Group 2 Innate Lymphoid Cells in the Airways following inhaled Allergen Challenge in Subjects with Mild Asthma

Roma Sehmi, Canada

Metabolomics of Circulating Human Memory CD4+T effector and T regulatory Cells Reveals that Phenylalanine is a Metabolic Checkpoint of Pathogenic Th2 Cells Development

Milena Sokolowska,  Switzerland

Differences In Th2 Population Sizes Between Atopic and Non-atopic Toddlers are not Established Until 36 Months of Age

Caitlin M. Burk, United States

Elevated CD27-IgD Double Negative B Cells in Eosinophilic Granulomatosis with Polyangiitis Patients Associated with Serum Anca Status

Nadia Suray Tan, Canada

Histidine Decarboxylase Expression in Human CD4 T cells

Binh Nguyen, Canada

Treatment of Non-Allergic Immune Disorders

Effective Delivery of miR-511-3p with Mannose-Decorated Exosomes with RNA Nanoparticles Confers Protection against Asthma

Peisong Gao, United States

New Outcomes on the Role of Histamine H4R and Gilz Anti-inflammatory Effects in Bleomycin-induced Pulmonary Fibrosis Model

Laura Lucarini, Italy

High Prevalence of Airway Hyperresponsiveness Among Adults with Symptomatic Asthma and Comorbid Obesity

Katherine Cahill, United States

A Surfactant Protein-A Peptide Modulates Responses to Interleukin-13 in Asthma and Offers a Novel Therapeutic Alternative

Monica Kraft, United States

The Concept of Disease Modification in Atopic Dermatitis:   Scientific and Regulatory Challenges for Drug Discovery and Development

Thomas Bieber, Germany

Characterization of Intrinsic Atopic Dermatitis Revisited using Multiplex Allergy Diagnostics

Thomas Bieber, Germany

The Severity of Allergic Rhinitis is Related to Sleep Disturbances in Korean Children and Adolescents

Yeong Ho Rha, Korea

7:00 am – 8:00 am

Breakfast

8:00 am – 10:00 am

Oral Abstract Session 5: Mechanisms of Asthma

Chair: Sally E. Wenzel, United States

8:00 am – 8:20 am

A Novel Machine Learning Pipeline Reveals Pathogenic Determinants of Systemic Adaptive Responses to Rhinovirus in Patients with Asthma

Judith A. Woodfolk, United States

8:20 am – 8:40 am

Non-Type 2 Inflammatory Markers Predict Post-Operative Nasal Polyp Recurrence in Aspirin-Exacerbated Respiratory Disease

Kathleen M. Buchheit, United States

8:40 am – 9:00 am

Plasma Siglec-6 as a Potential New Biomarker in Systemic Mastocytosis

Gunnar Nilsson, Sweden

9:00 am – 9:20 am

Nasal Gene Expression Patterns Predict Responsiveness to Mepolizumab Therapy in Urban Children with Exacerbation Prone Asthma

Daniel J. Jackson, United States

9:20 am – 9:40 am

Direct Activation of Airway Sensory C-fibers by SARS-CoV-2 Spike Protein

Bradley J. Undem, United States

9:40 am – 10:00 am

Non-T2 cytokines, IL-1ß and IL-18 Drive Plasticity of Airway ILC2 to Intermediate ILC2/3 Phenotype in Severe Asthma with Neutrophilic or Mixed Granulocytic Bronchitis

Roma Sehmi, Canada

10:00 – 10:30 am

Break

10:30 am – 11:30 am

Oral Abstract Session 6: Precision Medicine in Allergy

Chair: Thomas Bieber, Germany

10:30 am – 10:50 am

In Vivo Monitoring of Allergen-Specific Memory B-Cells: Tracking Development and Persistence

Willem Van de Veen, Switzerland

10:50 am – 11:10 am

Tackling Allergy with Genome Engineering: Deleting Cat Allergen Fel d 1 Using CRISPR Editing

Nicole Brackett, United States

11:10 am – 11:30 am

Janus Kinase Inhibitors Partly Restore the Toll-like Receptor 2 Responsiveness in Desensitized Human Langerhans Cells Via Down-regulation of Inhibitory Suppressor of Cytokine Signaling 1, but not Interleukin-1 Receptor Associated Kinase M

Nadine Herrmann, Germany

11:45 am – 12:30 pm

CIA Business Meeting

12:30 pm – 2:00 pm

Lunch

2:00 pm – 2:50 pm

Paul Kallos Memorial Lecture: Microbial Future-proofing - How Early Life Microbiomes Shape Immune Function and Childhood Allergy

Chair: Joshua Boyce, United States

Susan Lynch, United States

2:50 pm – 3:15 pm

Break

3:15 pm – 5:15 pm

Oral Abstract Session 7: Environmental Factors and Pathophysiology

Chair: Thomas A.E Platts-Mills, United States

3:15 pm – 3:35 pm

Allergen Exposure in Early Life is Associated with Systemic Immune Development in Disadvantaged Urban Children

James E. Gern, United States

3:35 pm – 3:55 pm 

Milk-Responsive T cells in Eosinophilic Esophagitis Display Unique Disease-Associated Cytokine Profiles in Both Tissue and Peripheral Blood

Cecilia Berin, United States

3:55 pm – 4:15 pm

Human Germline Heterozygous Gain-of-Function STAT6 Variants Cause Severe Allergic Disease

Stuart Turvey, Canada

4:15 pm – 4:35 pm

Patients with Aspirin Exacerbated Respiratory Disease are More Likely to have a Mixed Endotype and the R Allele of the Q576R Polymorphism than Patients with Chronic Rhinosinusitis with Nasal Polyps

Whitney Stevens, United States

4:35 pm – 4:55 pm

Specific B cell Responses in Allergen-specific Immunotherapy

Mubeccel Akdis, Switzerland

4:55 pm – 5:15 pm

Human IgE Monoclonal Antibody Interactions with Mite Allergen Der p 2 Define the Structural Basis for Anaphylaxis In Vivo

Anna Pomés, United States

7:00 pm

Gala Dinner

7:00 am – 8:00 am

Breakfast

8:00 am – 10:00 am

Oral Abstract Session 8: Allergen Exposure and Immunotherapy

Chair:  Hans Oettgen, United States

8:00 am – 8:20 am

Plant-based Enveloped Ara h 2 Bioparticles Display Exceptional Hypo-allergenicity and Activate Human Dendritic Cells to Promote Th1 Cell Development

Charlotte Castenmiller,  Netherlands

8:20 am – 8:40 am

Oral Immunotherapy in Children Aged 1 to <4 Years with Peanut Allergy: POSEIDON Trial Outcomes, Including Age Stratification

Andrea Vereda,  Switzerland

8:40 am – 9:00 am

The Effect of Treatment Duration on Efficacy During Oral Immunotherapy Using Heat-Modified Peanut: Results from the BOPI (Boiled Peanut Oral Immunotherapy) Study

Nandinee Patel, United Kingdom

9:00 am – 9:20 am

KLRG1hiIL17Rb1+ ILC2s Precede Eosinophil Recruitment into Remote Lungs Following Systemic Allergen Sensitization and Oral Allergen Challenge

Lisa A. Spencer, United States

9:20 am – 9:40 am

IgA Exhibits Calcium- and Sialic Acid-dependent Binding to Mast Cells and Inhibits IgE-mediated Activation in an Antigen-Specific Fashion

Yasmeen S. El Ansari, United States

9:40 am – 10:00 am

Characterizing Allergenicity and Immunogenicity of a Novel Peanut Allergen-Containing Enveloped Bioparticle

Karina E. Canziani, United States

10:00 am – 10:30 am

Break

10:30 am – 11:30 am

Presidential Lecture: The Long and Winding Road to Siglec-based Therapeutic Strategies

Chair: Thomas Bieber, Germany

Bruce S. Bochner, United States

11:30 am – 11:45 am

Closing Remarks

Thomas Bieber, Germany
Judah Denburg, Canada